Prolonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for Relapsed/Refractory Multiple Myeloma in Routine Clinical Care in the United States

Prolonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for... Micro-AbstractDespite the emerging paradigm favoring continuous therapy, we found that in routine clinical care, myeloma patients at first relapse frequently discontinue treatment before progression, resulting in a therapy duration that is significantly shorter than the interval to the next therapy. We further describe the association between the length of second-line therapy and improved overall survival for patients with relapsed/refractory multiple myeloma. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Lymphoma Myeloma and Leukemia Elsevier

Prolonged Duration of Therapy Is Associated With Improved Survival in Patients Treated for Relapsed/Refractory Multiple Myeloma in Routine Clinical Care in the United States

Loading next page...
 
/lp/elsevier/prolonged-duration-of-therapy-is-associated-with-improved-survival-in-FdIZGdPfZ7
Publisher
Elsevier
Copyright
Copyright © 2018 The Authors
ISSN
2152-2650
eISSN
2152-2669
D.O.I.
10.1016/j.clml.2017.12.012
Publisher site
See Article on Publisher Site

Abstract

Micro-AbstractDespite the emerging paradigm favoring continuous therapy, we found that in routine clinical care, myeloma patients at first relapse frequently discontinue treatment before progression, resulting in a therapy duration that is significantly shorter than the interval to the next therapy. We further describe the association between the length of second-line therapy and improved overall survival for patients with relapsed/refractory multiple myeloma.

Journal

Clinical Lymphoma Myeloma and LeukemiaElsevier

Published: Feb 1, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from Google Scholar, PubMed
Create lists to organize your research
Export lists, citations
Access to DeepDyve database
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off